9:50-10:05 AM:    Ganesh Raghu, MD
                              Definition of IPF; Incidence, Prevalence and Conceptual schema of
                              possible paths that lead to dysfunctional and scarred lung

10:05-10:25 AM:   Christine Garcia, MD, PhD (Asst. Professor of Medicine, Southwestern University, Dallas, TX)
                              Why Do Only Some People and some family members seem to be 'cursed' to get the Disease?
                              Do genetic factors determine this? If so, what are the knowns and unknowns?

10:25-10:45 AM:   Harold R. Collard, MD (Asst. Professor of Medicine, University of San Francisco, San Francisco, CA)
                              Natural Course of IPF and progression to stages of increased pressure system within the fibrotic lungs
                              (Secondary Pulmonary hypertension)

10:45-11:05 AM:   Michael Mulligan, MD (Associate Professor of Surgery,
                              University of Washington Medical Center, Seattle, WA)
                              Surgical Lung Biopsy and Lung Transplantation: From the eyes and hands of the Thoracic surgeon

11:35-11:55 AM:   Kevin Leslie, MD (Professor of Pathology, Mayo Clinic, Scottsdale, AZ)
                              The 'show and tell' of the microscopic and macroscopic features of the 'fibrotic lung'

1:15-1:35 PM:       Steve Crogan, R.T(Rehabilitation Services, University of Washington Medical Center, Seattle, WA)
                              The importance and knowhow's of being able to do more physical activities despite being having not 'enough air'

1:35-1:55 PM:       Carolyn Spada RN, BSN/Jennifer Hayes RN, BSN (Interstitial Lung Disease Nurse Coordinators,
                              Interstitial Lung Disease Clinic and Program, University of Washington Medical Center, Seattle, WA)
                              The essentials of Tests done for Evaluation and Monitoring IPF

1:55-2:25 PM:       Ganesh Raghu, MD
                             Treatment: Clinical trials and concerns with current approach while
                              pursuing evidence to improve outcome for patients with IPF

2:25- 2:45 PM:       Margaret (Peg) Snyder, RN, MN: Nurse Coordinator for NIH sponsored clinical trials -
                              (Interstitial Lung Disease Clinic and Program, University of Washington Medical Center, Seattle, WA)
                              Clinical trials: The hoops and hurdles of enrollment, compliance an adherence to study protocols'